Post-transcriptional regulation of VEGF-A mRNA levels by mitogen-activated protein kinases (MAPKs) during metabolic stress associated with ischaemia/reperfusion

Molecular and Cellular Biochemistry

Volumn 367, Issue 1-2, 2012, Pages 31-42

  Miller, Bryan W ^a   Hay, Joanna M ^a   Prigent, Sally A ^a   Dickens, Martin ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Angiogenesis; Metabolic stress; Mitogen activated protein kinase; Vascular endothelial growth factor

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; VASCULOTROPIN A;

5' UNTRANSLATED REGION; ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL LINE; CELL STRESS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ISCHEMIA; METABOLIC STRESS; NONHUMAN; POSTTRANSCRIPTIONAL GENE SILENCING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REPERFUSION; RNA STABILITY;

ANIMALS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN KINASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; REPERFUSION INJURY; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA STABILITY; RNA, MESSENGER; STRESS, PHYSIOLOGICAL; TRANSCRIPTIONAL ACTIVATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 84863457045     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1316-9     Document Type: Article

References (46)

1. Operschall C, Falivene L, Clozel JP, Roux S (2000) A new model of chronic cardiac ischemia in rabbits. J Appl Physiol 88(4):1438-1445 (Pubitemid 30217447)
2. Plate KH, Breier G, Weich HA, Risau W (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359(6398):845-848
3. Shammas NW, Moss AJ, Sullebarger JT, Gutierrez OH, Rocco TA (1993) Acquired coronary angiogenesis after myocardial infarction. Cardiology 83(3):212-216 (Pubitemid 23332071)
4. Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473(7347):298-307
5. Matsumoto T, Claesson-Welsh L (2001) VEGF receptor signal transduction. Sci STKE 2001(112):RE21
6. Shibuya M, Ito N, Claesson-Welsh L (1999) Structure and function of vascular endothelial growth factor receptor-1 and -2. Curr Top Microbiol Immunol 237:59-83 (Pubitemid 28554859)
7. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH (1994) Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269(43):26988-26995 (Pubitemid 24332901)
8. Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G, Keshet E (1994) Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res 28(8):1176-1179 (Pubitemid 24264723)
9. Hashimoto E, Ogita T, Nakaoka T, Matsuoka R, Takao A, Kira Y (1994) Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am J Physiol 267(5 Pt 2):H1948-H1954
10. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistlethwaite PA (2000) Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 342(9):626-633 (Pubitemid 30118415)
11. Becker PM, Alcasabas A, Yu AY, Semenza GL, Bunton TE (2000) Oxygen-independent upregulation of vascular endothelial growth factor and vascular barrier dysfunction during ventilated pulmonary ischemia in isolated ferret lungs. Am J Respir Cell Mol Biol 22(3):272-279 (Pubitemid 30343353)
12. Marti HJ, Bernaudin M, Bellail A, Schoch H, Euler M, Petit E, Risau W (2000) Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 156(3):965-976 (Pubitemid 30626954)
13. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, Vandendriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, Persico MG (2001) Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7(5):575-583 (Pubitemid 32448325)
14. Levy AP, Levy NS, Loscalzo J, Calderone A, Takahashi N, Yeo KT, Koren G, Colucci WS, Goldberg MA (1995) Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res 76(5):758-766
15. Levy AP, Levy NS, Wegner S, Goldberg MA (1995) Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 270(22):13333-13340
16. Levy AP, Levy NS, Goldberg MA (1996) Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 271(5):2746-2753 (Pubitemid 26047892)
17. Enholm B, Paavonen K, Ristimaki A, Kumar V, Gunji Y, Klefstrom J, Kivinen L, Laiho M, Olofsson B, Joukov V, Eriksson U, Alitalo K (1997) Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 14(20):2475-2483 (Pubitemid 27268166)
18. Bellomo D, Headrick JP, Silins GU, Paterson CA, Thomas PS, Gartside M, Mould A, Cahill MM, Tonks ID, Grimmond SM, Townson S, Wells C, Little M, Cummings MC, Hayward NK, Kay GF (2000) Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ Res 86(2):E29-E35
19. Witzenbichler B, Asahara T, Murohara T, Silver M, Spyridopoulos I, Magner M, Principe N, Kearney M, Hu JS, Isner JM (1998) Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol 153(2):381-394 (Pubitemid 28373650)
20. Hausenloy DJ, Yellon DM (2006) Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res 70(2):240-253
21. Kyriakis JM, Avruch J (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81(2):807-869 (Pubitemid 32267078)
22. Wang Y (2007) Mitogen-activated protein kinases in heart development and diseases. Circulation 116(12):1413-1423
23. Bogoyevitch MA, Gillespie-Brown J, Ketterman AJ, Fuller SJ, Ben-Levy R, Ashworth A, Marshall CJ, Sugden PH (1996) Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ Res 79(2):162-173 (Pubitemid 26255867)
24. Punn A, Mockridge JW, Farooqui S, Marber MS, Heads RJ (2000) Sustained activation of p42/p44 mitogen-activated protein kinase during recovery from simulated ischaemia mediates adaptive cytoprotection in cardiomyocytes. Biochem J 350(Pt 3):891-899
25. Knight RJ, Buxton DB (1996) Stimulation of c-Jun kinase and mitogen-activated protein kinase by ischemia and reperfusion in the perfused rat heart. Biochem Biophys Res Commun 218(1):83-88 (Pubitemid 26034493)
26. Milanini J, Vinals F, Pouyssegur J, Pages G (1998) p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts. J Biol Chem 273(29):18165-18172 (Pubitemid 28334735)
27. Pages G, Berra E, Milanini J, Levy AP, Pouyssegur J (2000) Stress-activated protein kinases (JNK and p38/HOG) are essential for vascular endothelial growth factor mRNA stability. J Biol Chem 275(34):26484-26491
28. Rodriguez-Gabriel MA, Russell P (2008) Control of mRNA stability by SAPKs. Top Curr Genet 20:159-170. doi:10.1007/4735-2007-0248
29. Hescheler J, Meyer R, Plant S, Krautwurst D, Rosenthal W, Schultz G (1991) Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ Res 69(6):1476-1486
30. Nagarkatti DS, Sha'afi RI (1998) Role of p38 MAP kinase in myocardial stress. J Mol Cell Cardiol 30(8):1651-1664 (Pubitemid 28418654)
31. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ (1996) Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 271(2):736-741 (Pubitemid 26034921)
32. Harding SJ, Browne GJ, Miller BW, Prigent SA, Dickens M (2010) Activation of ASK1, downstream MAPKK and MAPK isoforms during cardiac ischaemia. Biochim Biophys Acta 1802(9):733-740
33. Esumi K, Nishida M, Shaw D, Smith TW, Marsh JD (1991) NADH measurements in adult rat myocytes during simulated ischemia. Am J Physiol 260(6 Pt 2):H1743-H1752
34. Coles LS, Bartley MA, Bert A, Hunter J, Polyak S, Diamond P, Vadas MA, Goodall GJ (2004) A multi-protein complex containing cold shock domain (Y-box) and polypyrimidine tract binding proteins forms on the vascular endothelial growth factor mRNA. Potential role in mRNA stabilization. Eur J Biochem 271(3):648-660 (Pubitemid 38183639)
35. Du M, Roy KM, Zhong L, Shen Z, Meyers HE, Nichols RC (2006) VEGF gene expression is regulated post-transcriptionally in macrophages. FEBS J 273(4):732-745. doi:10.1111/j.1742-4658.2006.05106.x
36. Iida K, Kawakami Y, Sone H, Suzuki H, Yatoh S, Isobe K, Takekoshi K, Yamada N (2002) Vascular endothelial growth factor gene expression in a retinal pigmented cell is up-regulated by glucose deprivation through 30 UTR. Life Sci 71(14):1607-1614 (Pubitemid 34874487)
37. Onesto C, Berra E, Grepin R, Pages G (2004) Poly(A)-binding protein-interacting protein 2, a strong regulator of vascular endothelial growth factor mRNA. J Biol Chem 279(33):34217-34226. doi:10.1074/jbc.M400219200 (Pubitemid 39318045)
38. Goldberg-Cohen I, Furneauxb H, Levy AP (2002) A 40-bp RNA element that mediates stabilization of vascular endothelial growth factor mRNA by HuR. J Biol Chem 277(16):13635-13640 (Pubitemid 34967963)
39. Shih SC, Claffey KP (1999) Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L. J Biol Chem 274(3):1359-1365
40. Dibbens JA, Miller DL, Damert A, Risau W, Vadas MA, Goodall GJ (1999) Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements. Mol Biol Cell 10(4):907-919 (Pubitemid 29193720)
41. Chen CY, Gherzi R, Andersen JS, Gaietta G, Jurchott K, Royer HD, Mann M, Karin M (2000) Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. Genes Dev 14(10):1236-1248 (Pubitemid 30327504)
42. Essafi-Benkhadir K, Pouyssegur J, Pages G (2010) Implication of the ERK pathway on the post-transcriptional regulation of VEGF mRNA stability. Methods Mol Biol 661:451-469. doi:10.1007/978-1-60761-795-2-28
43. Yang Z, Zhang X, Darrah PA, Mosser DM (2010) The regulation of Th1 responses by the p38 MAPK. J Immunol 185(10):6205-6213. doi:10.4049/jimmunol. 1000243
44. Bhattacharyya S, Gutti U, Mercado J, Moore C, Pollard HB, Biswas R (2011) MAPK signaling pathways regulate IL-8 mRNA stability and IL-8 protein expression in cystic fibrosis lung epithelial cell lines. Am J Physiol Lung Cell Mol Physiol 300(1):L81-L87. doi:10.1152/ajplung.00051.2010
45. Lin WN, Lin CC, Cheng HY, Yang CM (2011) Regulation of cyclooxygenase-2 and cytosolic phospholipase A(2) gene expression by lipopolysaccharide through the RNA-binding protein HuR: involvement of NADPH oxidase, reactive oxygen species and mitogen-activated protein kinases. Br J Pharmacol 163(8):1691-1706. doi:10.1111/j.1476-5381.2011.01312.x
46. Schagger H, von Jagow G (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166(2):368-379 (Pubitemid 18004907)